Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-Biokompleks (also known as L-Biocomplex) is a liposomal dietary supplement developed and manufactured by Farmstandart-Biolik in Ukraine. It is a combination product consisting of two separate liposomal solutions: L-carnitine tartrate and thioctic acid (alpha-lipoic acid). L-Biokompleks is designed to support cellular energy metabolism, cardiovascular health, and liver function. L-carnitine facilitates the transport of long-chain fatty acids into the mitochondria for beta-oxidation, while thioctic acid acts as a potent antioxidant and an essential cofactor for mitochondrial multienzyme complexes such as pyruvate dehydrogenase. The supplement is used as an adjunct therapy for chronic heart failure, metabolic syndrome, chronic hepatitis, hepatic cirrhosis, non-alcoholic steatohepatitis, and stroke.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on L-Biokompleks.